Hypogonadism in Male Sexual Dysfunction

作者: Dana Stoian , Ioana Mozos , Marius Craina , Corina Paul , Iulian Velea

DOI: 10.5772/INTECHOPEN.69107

关键词:

摘要: Normal testosterone level is influencing all the steps of the male psychosexual development: intrauterine neonatal and final psychosexual development.. At pubertal stage, the quality of testosterone secretion is conditioning the development of the mature male phenotype. In adult life, eugonadism sustains desire, arousal, determines spontaneous erections, facilitates stimulated erection, influencing the response rate to medication. Moreover, eugonadism sustain daydreaming and phantasies, both needed for a normal sexual life. The pathogenic mechanism of all these actions is presented. Talking about hypogonadism means not only the classical types of hypogonadism: due to classical testicular disease of central, hypothalamic and hypophysis disease, but also the partial testosterone deficiency induces by aging (late onset hypogonadism), weight increase (up to 30% of males with metabolic syndrome and 50% of males with diabetes) or secondary hypogonadism described in chronic use of steroids or after long exposure to stress, especially in young males. All these types of hypogonadism, that affect young, middle aged or old males will be presented separately. A therapeutic approach that is individualized for each type of hypogonadism, should consider positive and possible negative effects and all alternatives will be presented: life style changes, sustained weight loss, increase exercise, supplemental therapy, pro fertility treatment.

参考文章(126)
Craig A. Smith, Andrew H. Sinclair, The Cell Biology and Molecular Genetics of Testis Determination Results and Problems in Cell Differentiation. ,vol. 28, pp. 23- 52 ,(2000) , 10.1007/978-3-540-48461-5_2
M.M. McCarthy, G.J. de Vries, N.G. Forger, Sexual Differentiation of the Brain: Mode, Mechanisms, and Meaning Hormones, brain and behavior. ,vol. 54, pp. 1707- 1746 ,(2009) , 10.1016/B978-008088783-8.00054-1
M Krotkiewski, P Björntorp, P Mårin, Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues The European journal of medicine. ,vol. 1, pp. 329- 336 ,(1992)
NATHALIE JOSSO, RICHARD L. CATE, JEAN-YVES PICARD, BERNARD VIGIER, NATHALIE DI CLEMENTE, CHERYL WILSON, SANDRINE IMBEAUD, R. BLAKE PEPINSKY, DANIEL GUERRIER, LAURENCE BOUSSIN, LAURENCE LEGEAI, DANIÈLE CARRÉ-EUSÈBE, Anti-müllerian hormone: the Jost factor. Recent Progress in Hormone Research. ,vol. 48, pp. 1- 59 ,(1993) , 10.1016/B978-0-12-571148-7.50005-1
Stephen B. Levine, The nature of sexual desire: a clinician's perspective. Archives of Sexual Behavior. ,vol. 32, pp. 279- 285 ,(2003) , 10.1023/A:1023421819465
Mark R. Palmert, Leo Dunkel, Delayed Puberty New England Journal of Medicine. ,vol. 366, pp. 443- 453 ,(2012) , 10.1056/NEJMCP1109290
Ronald W. Lewis, Christopher M. Reilly, Thomas M. Mills, Androgens and Penile Erection: A Review Journal of Andrology. ,vol. 17, pp. 633- 638 ,(1996) , 10.1002/J.1939-4640.1996.TB01847.X
Arthur L. Burnett, Neurophysiology of erectile function: androgenic effects. Journal of Andrology. ,vol. 24, ,(2003) , 10.1002/J.1939-4640.2003.TB02741.X
Thomas G. Travison, Rebecca Shackelton, Andre B. Araujo, Susan A. Hall, Rachel E. Williams, Richard V. Clark, Amy B. O'Donnell, John B. McKinlay, The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission. Journal of the American Geriatrics Society. ,vol. 56, pp. 831- 839 ,(2008) , 10.1111/J.1532-5415.2008.01679.X
L Sjostrom, P Bjorntorp, H Kvist, G Lindstedt, P Marin, G Holm, L Jonsson, S Holmang, The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. International Journal of Obesity. ,vol. 16, pp. 991- 997 ,(1992)